Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17–48.

Article  PubMed  Google Scholar 

Denkert C, Liedtke C, Tutt A, von Minckwitz G. Molecular alterations in triple-negative breast cancer-the road to new treatment strategies. Lancet. 2017;389(10087):2430–42.

Article  CAS  PubMed  Google Scholar 

Crusz SM, Balkwill FR. Inflammation and cancer: advances and new agents. Nat Rev Clin Oncol. 2015;12(10):584–96.

Article  CAS  PubMed  Google Scholar 

Vyas D, Laput G, Vyas AK. Chemotherapy-enhanced inflammation may lead to the failure of therapy and metastasis. Onco Target Ther. 2014;7:1015–23.

Article  Google Scholar 

Davoodi H, Hashemi SR, Seow HF. 5-Fluorouracil induce the expression of TLR4 on HCT116 colorectal cancer cell line expressing different variants of TLR4. Iran J Pharm Res. 2013;12(2):453–60.

CAS  PubMed  PubMed Central  Google Scholar 

Davoodi H, Hashemi SR, Seow HF. Increased NFk-B activity in HCT116 colorectal cancer cell line harboring TLR4 Asp299Gly variant. Iran J Allergy Asthma Immunol. 2012;11(2):121–32.

CAS  PubMed  Google Scholar 

Nokhandani N, Naghavi Alhosseini M, Memarian A, Davoodi H. Combination of 5-fluorouracil and lipopolysaccharide synergistically induces cytotoxicity and apoptosis in MCF-7 human breast cancer CELLS. Iran J Allergy Asthma Immunol. 2020;19(4):426–36.

PubMed  Google Scholar 

Stepaniuk P, Kanani A. Malignancy and immune disorders in patients with hereditary angioedema. Allergy Asthma Clin Immunol. 2021;17(1):134.

Article  PubMed  PubMed Central  Google Scholar 

DeSantis CE, Ma J, Gaudet MM, Newman LA, Miller KD, Goding Sauer A, et al. Breast cancer statistics, 2019. CA Cancer J Clin. 2019;69(6):438–51.

Article  PubMed  Google Scholar 

Danforth DN. The role of chronic inflammation in the development of breast cancer. Cancers (Basel). 2021;13:3918.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao H, Wu L, Yan G, Chen Y, Zhou M, Wu Y, et al. Inflammation and tumor progression: signaling pathways and targeted intervention. Signal Transduct Target Ther. 2021;6(1):263.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Medina VA, Martinel D, Brenzoni P, Massari N, Carabajal E, Rivera E. Histamine receptors as potential therapeutic targets for cancer drug development. Drug Dev Case Study Based Insight Mod Strateg. 2011:75–100.

Davio C, Cricco G, Martin G, Fitzsimons C, Bergoc R, Rivera E. Effect of histamine on growth and differentiation of the rat mammary gland. Agent Action. 1994;41:C115–7.

Article  CAS  Google Scholar 

Nicoud MB, Sterle HA, Massari NA, Taquez Delgado MA, Formoso K, Herrero Ducloux MV, et al. Study of the antitumour effects and the modulation of immune response by histamine in breast cancer. Br J Cancer. 2020;122(3):348–60.

Article  CAS  PubMed  Google Scholar 

Martinel Lamas DJ, Nicoud MB, Sterle HA, Cremaschi GA, Medina VA. Histamine: a potential cytoprotective agent to improve cancer therapy? 2015.

Fritz I, Wagner P, Olsson H. Improved survival in several cancers with use of H1-antihistamines desloratadine and loratadine. Transl Oncol. 2021;14(4): 101029.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen S, Luster AD. Antihistamines for cancer immunotherapy: more than just treating allergies. Cancer Cell. 2022;40(1):9–11.

Article  CAS  PubMed  Google Scholar 

Massari NA, Nicoud MB, Medina VA. Histamine receptors and cancer pharmacology: an update. Br J Pharmacol. 2020;177(3):516–38.

Article  CAS  PubMed  Google Scholar 

Maintz L, Novak N. Histamine and histamine intolerance. Am J Clin Nutr. 2007;85(5):1185–96.

Article  CAS  PubMed  Google Scholar 

Faustino-Rocha AI, Ferreira R, Gama A, Oliveira PA, Ginja M. Antihistamines as promising drugs in cancer therapy. Life Sci. 2017;172:27–41.

Article  CAS  PubMed  Google Scholar 

Van Schoor J. Antihistamines: a brief review: clinical. Prof Nurs Today. 2012;16(5):16–21.

Google Scholar 

Ferrara AL, Cristinziano L, Petraroli A, Bova M, Gigliotti MC, Marcella S, et al. Roles of immune cells in hereditary angioedema. Clin Rev Allergy Immunol. 2021;60(3):369–82.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Garcia-Caballero M, Neugebauer E, Rodriguez F, De Castro IN, Vara-Thorbeck C. Histamine synthesis and content in benign and malignant breast tumours. its effects on other host tissues. Surg Oncol. 1994;3:167–73.

Article  CAS  PubMed  Google Scholar 

Grahn B, Rosengren E. Retardation of protein synthesis in rat tumours on inhibiting histamine formation. Experientia. 1970;26(2):125–6.

Article  CAS  PubMed  Google Scholar 

Moriarty CM, Stucky JL, Hamburger KW, Patil KD, Foley JF, Koefoot RR. Blood histamine and solid malignant tumors. J Cancer Res Clin Oncol. 1988;114(6):588–92.

Article  CAS  PubMed  Google Scholar 

Rivera ES, Cricco GP, Engel NI, Fitzsimons CP, Martı́n GA, Bergoc RM. Histamine as an autocrine growth factor: an unusual role for a widespread mediator. Seminars in Cancer Biology. 2000;10(1):15-23.

Martinel Lamas DJ, Croci M, Carabajal E, Crescenti EJV, Sambuco L, Massari NA, et al. Therapeutic potential of histamine H4 receptor agonists in triple-negative human breast cancer experimental model. Br J Pharmacol. 2013;170(1):188–99.

Article  PubMed  PubMed Central  Google Scholar 

Lamas D, Nicoud MB, Sterle HA, Carabajal E, Tesan F, Perazzo JC, et al. Selective cytoprotective effect of histamine on doxorubicin-induced hepatic and cardiac toxicity in animal models. Cell death discov. 2015;1(1):1–11.

Article  Google Scholar 

Martinel Lamas DJ, Cortina JE, Ventura C, Sterle HA, Valli E, Balestrasse KB, et al. Enhancement of ionizing radiation response by histamine in vitro and in vivo in human breast cancer. Cancer Biol Ther. 2015;16(1):137–48.

Article  CAS  PubMed  Google Scholar 

Galarza TE, Mohamad NA, Delgado MAT, Vedoya GM, Crescenti EJ, Bergoc RM, et al. Histamine prevents radiation-induced mesenchymal changes in breast cancer cells. Pharmacol Res. 2016;111:731–9.

Article  CAS  PubMed  Google Scholar 

Akdis C, Blaser K, Akdis M. Genes of tolerance. Allergy. 2004;59(9):897–913.

Article  CAS  PubMed  Google Scholar 

Leurs R, Church M, Taglialatela M. H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects. Clin Exp Allerg. 2002;32(4):489–98.

Article  CAS  Google Scholar 

Bakker RA, Schoonus SB, Smit MJ, Timmerman H, Leurs R. Histamine H(1)-receptor activation of nuclear factor-kappa B: roles for G beta gamma- and G alpha(q/11)-subunits in constitutive and agonist-mediated signaling. Mol Pharmacol. 2001;60(5):1133–42.

Article  CAS  PubMed  Google Scholar 

Fernández-Nogueira P, Bragado P, Almendro V, Ametller E, Rios J, Choudhury S, et al. Differential expression of neurogenes among breast cancer subtypes identifies high risk patients. Oncotarget. 2016;7(5):5313–26.

Article  PubMed  Google Scholar 

Li H, Xiao Y, Li Q, Yao J, Yuan X, Zhang Y, et al. The allergy mediator histamine confers resistance to immunotherapy in cancer patients via activation of the macrophage histamine receptor H1. Cancer Cell. 2022;40(36–52):9.

CAS  Google Scholar 

Yang XD, Ai W, Asfaha S, Bhagat G, Friedman RA, Jin G, et al. Histamine deficiency promotes inflammation-associated carcinogenesis through reduced myeloid maturation and accumulation of CD11b+Ly6G+ immature myeloid cells. Nat Med. 2011;17(1):87–95.